BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 28125091)

  • 21. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
    Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
    Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
    Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
    Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
    Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
    Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
    Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
    Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.
    Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X
    PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
    Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
    Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.
    Gururajan M; Josson S; Chu GC; Lu CL; Lu YT; Haga CL; Zhau HE; Liu C; Lichterman J; Duan P; Posadas EM; Chung LW
    Clin Cancer Res; 2014 Dec; 20(24):6559-69. PubMed ID: 25324143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-539 inhibits human colorectal cancer progression by targeting RUNX2.
    Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
    Biomed Pharmacother; 2017 Nov; 95():1314-1320. PubMed ID: 28938522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
    Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
    Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
    Hong X; Yu JJ
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
    Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
    Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-196b Inhibits Cell Growth and Metastasis of Lung Cancer Cells by Targeting Runx2.
    Bai X; Meng L; Sun H; Li Z; Zhang X; Hua S
    Cell Physiol Biochem; 2017; 43(2):757-767. PubMed ID: 28950255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
    Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
    Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
    Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
    Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.